Literature DB >> 16148550

Report of a collaborative trial to investigate the performance of the R5 enzyme linked immunoassay to determine gliadin in gluten-free food.

Enrique Méndez1, Carmen Vela, Ulrike Immer, Frederik W Janssen.   

Abstract

OBJECTIVE: Analytical methods for measurements of gluten in the low level range of 20-200 ppm of gluten, as required for gluten-free food, have never been endorsed by the Codex Alimentarius. With the aim of investigating standardized and reliable methods for the detection of gliadin in food with detection limits lower than 200 ppm, as proposed by the Codex Alimentarius, the Working Group on Prolamin Analysis and Toxicity (WGPAT) coordinated a large collaborative study to validate a monoclonal antibody based ELISA, which uses an antibody (R5) against rye secalins.
METHODS: Twelve food samples in which gliadin was present in the range of 0-168 ppm were analysed with two different commercially available R5 ELISA tests and a special extraction solvent, based on a reducing and a dissociating agent designed to extract heat denatured proteins. Twenty laboratories participated in this study.
RESULTS: Recovery values ranged from 65 to 110% in general. The repeatability (RSDr) and reproducibility (RSDR) figures ranged between 13 and 25, resp. 23 and 47 for one test, and between 11 and 22, resp. 25 and 33 for the other.
CONCLUSION: Both assays are comparable and robust. The repeatability and reproducibility data are in a range that is acceptable for ELISAs. Kits from both suppliers fulfilled performance criteria of regular ELISA methods, and it is shown that both ELISA kits guarantee a sensitivity of 1.5 ppm gliadin for gluten-free food.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148550     DOI: 10.1097/00042737-200510000-00008

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

1.  Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.

Authors:  Na Tian; Guoxian Wei; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

2.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

3.  Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.

Authors:  Na Tian; Daniel A Leffler; Ciaran P Kelly; Joshua Hansen; Eric V Marietta; Joseph A Murray; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-01       Impact factor: 4.052

4.  Evolution of Gluten Content in Cereal-Based Gluten-Free Products: An Overview from 1998 to 2016.

Authors:  María Ángeles Bustamante; María Pilar Fernández-Gil; Itziar Churruca; Jonatan Miranda; Arrate Lasa; Virginia Navarro; Edurne Simón
Journal:  Nutrients       Date:  2017-01-03       Impact factor: 5.717

5.  E40 glutenase detoxification capabilities of residual gluten immunogenic peptides in in vitro gastrointestinal digesta of food matrices made of soft and durum wheat.

Authors:  Gianfranco Mamone; Maria Cristina Comelli; Serena Vitale; Luigia Di Stasio; Katharina Kessler; Ilaria Mottola; Francesco Siano; Linda Cavaletti; Carmen Gianfrani
Journal:  Front Nutr       Date:  2022-09-08

6.  Quantification of Hordeins by ELISA: the correct standard makes a magnitude of difference.

Authors:  Gregory J Tanner; Malcolm J Blundell; Michelle L Colgrave; Crispin A Howitt
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

7.  Gluten measurement and its relationship to food toxicity for celiac disease patients.

Authors:  Diane R Lester
Journal:  Plant Methods       Date:  2008-10-28       Impact factor: 4.993

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.